449 related articles for article (PubMed ID: 25589384)
1. Immunotherapy of melanoma: present options and future promises.
Rotte A; Bhandaru M; Zhou Y; McElwee KJ
Cancer Metastasis Rev; 2015 Mar; 34(1):115-28. PubMed ID: 25589384
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for the management of advanced melanoma: the next steps.
Zikich D; Schachter J; Besser MJ
Am J Clin Dermatol; 2013 Aug; 14(4):261-72. PubMed ID: 23516145
[TBL] [Abstract][Full Text] [Related]
3. Next generation of immunotherapy for melanoma.
Kirkwood JM; Tarhini AA; Panelli MC; Moschos SJ; Zarour HM; Butterfield LH; Gogas HJ
J Clin Oncol; 2008 Jul; 26(20):3445-55. PubMed ID: 18612161
[TBL] [Abstract][Full Text] [Related]
4. Melanoma immunotherapy: historical precedents, recent successes and future prospects.
Raaijmakers MI; Rozati S; Goldinger SM; Widmer DS; Dummer R; Levesque MP
Immunotherapy; 2013 Feb; 5(2):169-82. PubMed ID: 23413908
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy as an adjuvant therapy in the management of advanced, surgically resected, melanoma.
Kalani AD; Jack A; Montenegro G; Degliuomini J; Wallack MK
G Ital Dermatol Venereol; 2008 Feb; 143(1):59-70. PubMed ID: 18833052
[TBL] [Abstract][Full Text] [Related]
6. Cancer treatment: The killer within.
Ledford H
Nature; 2014 Apr; 508(7494):24-6. PubMed ID: 24695297
[No Abstract] [Full Text] [Related]
7. Immunotherapy in melanoma: Recent advances and future directions.
Franklin C; Livingstone E; Roesch A; Schilling B; Schadendorf D
Eur J Surg Oncol; 2017 Mar; 43(3):604-611. PubMed ID: 27769635
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for metastatic melanoma.
Zito CR; Kluger HM
J Cell Biochem; 2012 Mar; 113(3):725-34. PubMed ID: 22006439
[TBL] [Abstract][Full Text] [Related]
9. [Are immunological treatments beneficial for malignant melanoma of the skin?].
Vihinen P; Vuoristo MS; Hernberg M; Pyrhönen S
Duodecim; 2010; 126(14):1701-10. PubMed ID: 20804089
[TBL] [Abstract][Full Text] [Related]
10. Recent advances using anti-CTLA-4 for the treatment of melanoma.
Sarnaik AA; Weber JS
Cancer J; 2009; 15(3):169-73. PubMed ID: 19556898
[TBL] [Abstract][Full Text] [Related]
11. Novel immunotherapies as potential therapeutic partners for traditional or targeted agents: cytotoxic T-lymphocyte antigen-4 blockade in advanced melanoma.
Agarwala SS
Melanoma Res; 2010 Feb; 20(1):1-10. PubMed ID: 19952852
[TBL] [Abstract][Full Text] [Related]
12. Strategies to enhance the therapeutic activity of cancer vaccines: using melanoma as a model.
Berinstein NL
Ann N Y Acad Sci; 2009 Sep; 1174():107-17. PubMed ID: 19769743
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment with ipilimumab and intratumoral interleukin-2 in pretreated patients with stage IV melanoma-safety and efficacy in a phase II study.
Weide B; Martens A; Wistuba-Hamprecht K; Zelba H; Maier L; Lipp HP; Klumpp BD; Soffel D; Eigentler TK; Garbe C
Cancer Immunol Immunother; 2017 Apr; 66(4):441-449. PubMed ID: 28008452
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy of melanoma: an update.
Homsi J; Grimm JC; Hwu P
Surg Oncol Clin N Am; 2011 Jan; 20(1):145-63. PubMed ID: 21111964
[TBL] [Abstract][Full Text] [Related]
15. Melanoma immunotherapy.
Sivendran S; Glodny B; Pan M; Merad M; Saenger Y
Mt Sinai J Med; 2010; 77(6):620-42. PubMed ID: 21105125
[TBL] [Abstract][Full Text] [Related]
16. Beyond CTLA-4: novel immunotherapy strategies for metastatic melanoma.
Matikas A; Mavroudis D
Future Oncol; 2015; 11(6):997-1009. PubMed ID: 25760979
[TBL] [Abstract][Full Text] [Related]
17. Advances and perspectives in immunotherapy of melanoma.
Schadendorf D; Vaubel J; Livingstone E; Zimmer L
Ann Oncol; 2012 Sep; 23 Suppl 10():x104-8. PubMed ID: 22987943
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy in melanoma.
Feld E; Mitchell TC
Immunotherapy; 2018 Aug; 10(11):987-998. PubMed ID: 30149766
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral immunotherapy for melanoma.
Singh M; Overwijk WW
Cancer Immunol Immunother; 2015 Jul; 64(7):911-21. PubMed ID: 26050024
[TBL] [Abstract][Full Text] [Related]
20. Restoration of tumor equilibrium after immunotherapy for advanced melanoma: three illustrative cases.
Wilgenhof S; Pierret L; Corthals J; Van Nuffel AM; Heirman C; Roelandt T; De Coninck A; Verfaillie G; Vandenbroucke F; Van Riet I; Bonehill A; Thielemans K; Neyns B
Melanoma Res; 2011 Apr; 21(2):152-9. PubMed ID: 21317818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
